drugset / Trial / NCT07516925
A Study of Ivonescimab in People With Leiomyosarcoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unresectable leiomyosarcoma.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2029-04
- Completion
- 2029-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | — | Intravenous |